Stuttering priapism: Insights into pathogenesis and management

Belinda F. Morrison, Arthur Burnett

Research output: Contribution to journalArticle

Abstract

Priapism is defined as a persistent, painful erection that continues beyond, or is unrelated to, sexual stimulation. It may be categorized as either ischemic (low/absent flow) or nonischemic (high flow). Stuttering priapism is a variant of the ischemic type that is characterized by repetitive, transient, painful, self-limiting episodes of priapism. It is associated with various hematological disorders, including sickle cell disease and pharmacological treatments. The consequences of ineffective treatment of priapism are erectile dysfunction and impaired quality of life due to chronic pain and physical disfigurement. Many of the existing medical therapeutic options for treatment of stuttering priapism are nonmechanistic and associated with significant adverse effects. However, the scientific knowledge of stuttering priapism has transitioned in the past few years, from a condition that is poorly understood to one that has borne a burst of evolving molecular science. In this review, the pathophysiology of priapism is discussed, with particular emphasis on new molecular effectors and mechanisms. Novel treatment methods, as well as potential future agents, based on the emerging molecular evidence are discussed.

Original languageEnglish (US)
Pages (from-to)268-276
Number of pages9
JournalCurrent Urology Reports
Volume13
Issue number4
DOIs
StatePublished - Aug 2012

Fingerprint

Priapism
Stuttering
Therapeutics
Sickle Cell Anemia
Erectile Dysfunction
Chronic Pain
Quality of Life
Pharmacology

Keywords

  • Androgen
  • Erectile dysfunction
  • Erection
  • Ischemicpriapism
  • Nitric oxide
  • Penis
  • Phosphodiesterase type 5
  • Priapism
  • Sicklecelldisease
  • Stuttering priapism

ASJC Scopus subject areas

  • Urology

Cite this

Stuttering priapism : Insights into pathogenesis and management. / Morrison, Belinda F.; Burnett, Arthur.

In: Current Urology Reports, Vol. 13, No. 4, 08.2012, p. 268-276.

Research output: Contribution to journalArticle

@article{9edd1fbf06614213b164a19de870d68a,
title = "Stuttering priapism: Insights into pathogenesis and management",
abstract = "Priapism is defined as a persistent, painful erection that continues beyond, or is unrelated to, sexual stimulation. It may be categorized as either ischemic (low/absent flow) or nonischemic (high flow). Stuttering priapism is a variant of the ischemic type that is characterized by repetitive, transient, painful, self-limiting episodes of priapism. It is associated with various hematological disorders, including sickle cell disease and pharmacological treatments. The consequences of ineffective treatment of priapism are erectile dysfunction and impaired quality of life due to chronic pain and physical disfigurement. Many of the existing medical therapeutic options for treatment of stuttering priapism are nonmechanistic and associated with significant adverse effects. However, the scientific knowledge of stuttering priapism has transitioned in the past few years, from a condition that is poorly understood to one that has borne a burst of evolving molecular science. In this review, the pathophysiology of priapism is discussed, with particular emphasis on new molecular effectors and mechanisms. Novel treatment methods, as well as potential future agents, based on the emerging molecular evidence are discussed.",
keywords = "Androgen, Erectile dysfunction, Erection, Ischemicpriapism, Nitric oxide, Penis, Phosphodiesterase type 5, Priapism, Sicklecelldisease, Stuttering priapism",
author = "Morrison, {Belinda F.} and Arthur Burnett",
year = "2012",
month = "8",
doi = "10.1007/s11934-012-0258-9",
language = "English (US)",
volume = "13",
pages = "268--276",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Stuttering priapism

T2 - Insights into pathogenesis and management

AU - Morrison, Belinda F.

AU - Burnett, Arthur

PY - 2012/8

Y1 - 2012/8

N2 - Priapism is defined as a persistent, painful erection that continues beyond, or is unrelated to, sexual stimulation. It may be categorized as either ischemic (low/absent flow) or nonischemic (high flow). Stuttering priapism is a variant of the ischemic type that is characterized by repetitive, transient, painful, self-limiting episodes of priapism. It is associated with various hematological disorders, including sickle cell disease and pharmacological treatments. The consequences of ineffective treatment of priapism are erectile dysfunction and impaired quality of life due to chronic pain and physical disfigurement. Many of the existing medical therapeutic options for treatment of stuttering priapism are nonmechanistic and associated with significant adverse effects. However, the scientific knowledge of stuttering priapism has transitioned in the past few years, from a condition that is poorly understood to one that has borne a burst of evolving molecular science. In this review, the pathophysiology of priapism is discussed, with particular emphasis on new molecular effectors and mechanisms. Novel treatment methods, as well as potential future agents, based on the emerging molecular evidence are discussed.

AB - Priapism is defined as a persistent, painful erection that continues beyond, or is unrelated to, sexual stimulation. It may be categorized as either ischemic (low/absent flow) or nonischemic (high flow). Stuttering priapism is a variant of the ischemic type that is characterized by repetitive, transient, painful, self-limiting episodes of priapism. It is associated with various hematological disorders, including sickle cell disease and pharmacological treatments. The consequences of ineffective treatment of priapism are erectile dysfunction and impaired quality of life due to chronic pain and physical disfigurement. Many of the existing medical therapeutic options for treatment of stuttering priapism are nonmechanistic and associated with significant adverse effects. However, the scientific knowledge of stuttering priapism has transitioned in the past few years, from a condition that is poorly understood to one that has borne a burst of evolving molecular science. In this review, the pathophysiology of priapism is discussed, with particular emphasis on new molecular effectors and mechanisms. Novel treatment methods, as well as potential future agents, based on the emerging molecular evidence are discussed.

KW - Androgen

KW - Erectile dysfunction

KW - Erection

KW - Ischemicpriapism

KW - Nitric oxide

KW - Penis

KW - Phosphodiesterase type 5

KW - Priapism

KW - Sicklecelldisease

KW - Stuttering priapism

UR - http://www.scopus.com/inward/record.url?scp=84864844050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864844050&partnerID=8YFLogxK

U2 - 10.1007/s11934-012-0258-9

DO - 10.1007/s11934-012-0258-9

M3 - Article

C2 - 22648304

AN - SCOPUS:84864844050

VL - 13

SP - 268

EP - 276

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 4

ER -